The estimated Net Worth of Barbara W. Bodem is at least $5.72 Million dollars as of 6 December 2021. Ms. Bodem owns over 3,632 units of Hill-Rom Inc stock worth over $2,575,367 and over the last 7 years she sold HRC stock worth over $0. In addition, she makes $3,144,650 as Chief Financial Officer and Senior Vice President at Hill-Rom Inc.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Ms. Bodem HRC stock SEC Form 4 insiders trading
Barbara has made over 6 trades of the Hill-Rom Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently she exercised 3,632 units of HRC stock worth $566,447 on 6 December 2021.
The largest trade she's ever made was exercising 3,673 units of Hill-Rom Inc stock on 4 December 2019 worth over $391,285. On average, Barbara trades about 651 units every 32 days since 2017. As of 6 December 2021 she still owns at least 16,513 units of Hill-Rom Inc stock.
You can see the complete history of Ms. Bodem stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Barbara Bodem biography
Barbara W. Bodem is Chief Financial Officer, Senior Vice President of the Company effective December 3, 2018. Before joining Hillrom, she served as Senior Vice President, Finance at Mallinckrodt. Previously, she served in a variety of senior finance roles for Hospira, Inc. and Eli Lilly, including serving as CFO of Lilly Oncology.
What is the salary of Barbara Bodem?
As the Chief Financial Officer and Senior Vice President of Hill-Rom Inc, the total compensation of Barbara Bodem at Hill-Rom Inc is $3,144,650. There are 1 executives at Hill-Rom Inc getting paid more, with John Groetelaars having the highest compensation of $7,326,160.
How old is Barbara Bodem?
Barbara Bodem is 51, she's been the Chief Financial Officer and Senior Vice President of Hill-Rom Inc since 2018. There are 20 older and 5 younger executives at Hill-Rom Inc. The oldest executive at Hill-Rom Holdings Inc is William Kucheman, 70, who is the Independent Director.
What's Barbara Bodem's mailing address?
Barbara's mailing address filed with the SEC is C/O BIOMARIN PHARMACEUTICAL INC., 770 LINDARO STREET, SAN RAFAEL, CA, 94901.
Insiders trading at Hill-Rom Inc
Over the last 17 years, insiders at Hill-Rom Inc have traded over $30,589,508 worth of Hill-Rom Inc stock and bought 112,784 units worth $2,597,878 . The most active insiders traders include John J Greisch, W August Hillenbrand, and James R Giertz. On average, Hill-Rom Inc executives and independent directors trade stock every 20 days with the average trade being worth of $1,650,525. The most recent stock trade was executed by Andreas G Frank on 6 December 2021, trading 361 units of HRC stock currently worth $56,302.
What does Hill-Rom Inc do?
Hillrom Holdings Inc. is a global medical technology leader whose 10,000 employees have a single purpose: enhancing outcomes for patients and their caregivers by Advancing Connected Care™. Around the world, its innovations touch over 7 million patients each day. They help enable earlier diagnosis and treatment, optimize surgical efficiency and accelerate patient recovery while simplifying clinical communication and shifting care closer to home. The company makes these outcomes possible through connected smart beds, patient lifts, patient assessment and monitoring technologies, caregiver collaboration tools, respiratory health devices, advanced operating room equipment and more, delivering actionable, real-time insights at the point of care.
What does Hill-Rom Inc's logo look like?
Complete history of Ms. Bodem stock trades at Biomarin Pharmaceutical, Hill-Rom Inc, Invacare, Syneos Health Inc, Turning Point Therapeutics Inc, and Option Care Health
Hill-Rom Inc executives and stock owners
Hill-Rom Inc executives and other stock owners filed with the SEC include:
-
John Groetelaars,
President, Chief Executive Officer, Director -
Barbara Bodem,
Chief Financial Officer, Senior Vice President -
John P. Groetelaars,
Pres, CEO & Director -
Paul Johnson,
Senior Vice President, President of Patient Support Systems -
Andreas Frank,
Senior Vice President, President - Front Line Care Business -
Deborah Rasin,
Senior Vice President, Chief Legal Officer, Secretary -
Andreas G. Frank,
Sr. VP & Pres of Front Line Care business -
Barbara W. Bodem,
Sr. VP & CFO -
Paul S. Johnson,
Sr. VP & Pres of Patient Support Systems -
William Dempsey,
Non-Executive Independent Chairman of the Board -
Nancy Schlichting,
Independent Director -
Gary Ellis,
Independent Director -
Ronald Malone,
Independent Director -
James Giertz,
Independent Director -
William Kucheman,
Independent Director -
Mary Garrett,
Independent Director -
Stacy Seng,
Independent Director -
Gregory Moore,
Independent Director -
Ilana Shulman,
Chief Compliance Officer -
Anjana Harve,
Chief Information Officer -
Richard Wagner,
Chief Accounting Officer, Vice President, Controller -
Timothy Lawrence,
Senior Vice President - Operations -
Mary Ladone,
Senior Vice President - Corporate Development, Strategy and Investor Relations -
Brian Lawrence,
Chief Technology Officer -
Kenneth Meyers,
Chief Human Resource Officer, Senior Vice President -
Mary Kay Ladone,
Sr. VP of Corp. Devel., Strategy & Investor Relations -
Sue-Jean Lin,
Chief Information Officer & Sr. VP -
Brian Lawrence,
CTO & Sr. VP -
Richard M. Wagner,
VP, Controller & CAO -
Timothy P. Lawrence,
Sr. VP of Operations -
Dirk H Ehlers,
SVP President Surg Solutions -
Rolf A Classon,
Director -
Carlyn D Solomon,
Chief Operating Officer -
Eduardo S Menasce,
Director -
Kimberly K Ryan,
Group VP, N.A. Post Acute Care -
Perry Iii Stuckey,
Sr. VP and Chief HR Officer -
Gregory N Miller,
Senior VP & CFO -
Mark David Baron,
Sr. VP, Ops & Prod. Dev. -
Steven J Strobel,
Senior Vice President and CFO -
John J Greisch,
President and CEO -
Alton Shader,
Sr VP & Pres Post Acute Care -
Carlos Alonso Marum,
SVP, President International -
Jason Richardson,
VP, Controller & CAO -
Vega Francisco Canal,
SVP & Pres, Surgical Solutions -
Charles E Golden,
Director -
Gregory John Tucholski,
President, Int'l. & Surgical -
Peter H Soderberg,
President & CEO -
Maynadier Patrick D De,
Sr. VP, Gen. Counsel & Sec -
Sheri H. Edison,
Sr. VP & Chief Admin. Officer -
Chaofu Jeffrey Kao,
President, N.A. Acute Care -
Patrick T Ryan,
Director -
John H Dickey,
Vice President, Human Resource -
Kenneth A Camp,
Senior Vice President -
Rayj Hillenbrand,
Director -
Carli Earl Vincent De,
Group VP, Care Continuum Svc -
Susan R Lichtenstein,
Sr. VP & Chief Counsel -
Taylor Smith,
SVP & Pres Surg. Resp. -
Richard G Keller,
VP, Controller & CAO -
Scott R. Jeffers,
Sr. VP, Global Supply Chain -
Alejandro Infante Saracho,
President, International -
Michael Murphy,
Senior VP QA/RA -
Michael S. Macek,
VP, Treasurer and Interim CFO -
Michiel De Zwaan,
Senior VP Chief HR Officer -
W August Hillenbrand,
Director -
Michael O Oliver,
Senior VP Chief HR Officer -
Joanne C Dr Smith,
Director -
Mark Guinan,
Sr. VP and CFO -
Philip David Settimi,
Sr VP, Global Mktg & Corp. Str -
Martha Goldberg Aronson,
Sr. VP & Pres. N. America -
Edward Gregory Pritchard,
SVP & Pres Surg. Resp. -
Katherine S Zanotti,
Director -
Amy M. Dodrill,
President - Surgical Solutions -
Felicia F Norwood,